1.
Patel Vishakha. D. Raj Hasumati, Gheewala
Nirav,A Review on Analytical Methods for Ranolazine determination in synthetic
mixture; Pharma Tutor; 2016; 4(4); 28-31
2.
Priyanka Patil, Shyam Rangari, Priya
Patil, Research on analytical methods of analysis of Ranolazine: A Review,
Himalayan Journal of Health Sciences; 2020; 5(4);30-40.
3.
Zubaidur
Rahman, MohidulIslam, Moidul Islam Judder, Sadiqul Alam1,Moksood Ahmed Laskar, A
Review on Analytical Development and Determination Method of Ranolazine in
synthetic mixture; Indian Journal of Research in Pharmacy and Biotechnology
(IJRPB);2022;10 (1);18-27.
4.
Vivek
Nalawade, Parag Gide, Govind Nunnavare, Mitesh Phale, Development and
Validation of RP-HPLCMethod for the Determination of Ranolazine in Human
Plasma,International Journal of Pharmaceutical Sciences;2010;2(1):369-374.
5.
Erin Rayner‐Hartley , Tara Sedlak, Ranolazine: A Contemporary Review, National library of
medicine;2016;15;5(3);1-8.
6.
Reddy BM,
Weintraub HS, Schwartzbard AZ. Ranolazine: a new approach to treating an old
problem. Tex Heart Inst J. 2010;37(6):641-7.
7.
Al Batran R,
Gopal K, Aburasayn H, Eshreif A, Almutairi M, Greenwell AA, Campbell SA, Saleme
B, Court EA, Eaton F, Light PE, Sutendra G, Ussher JR. The antianginal
ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and
increases hepatic pyruvate dehydrogenase activity. JCI Insight. 2019
Jan 10;4(1).
8.
Parvatha
reddy S, Desam N, Nuthalapati M, B.T, Development and
Validation of HPLC and UV methods for estimation
of Ranolazine in Bulk and Marketed formulation , International
journal of Innovative Pharmaceutical Sciences and Research, 2014, 2(5),
1042-1058
9.
Patel
R.C, Rathod D.K, Patel P.R, Patel V.S, Estimation
of Ranolazine Hydrochloride by Spectrophotometric and RP-HPLC in
tablet dosage forms., International Journal of Pharmaceutical
and Applied Sciences, 2010, 1(2), 79-83
10.
VV.S,
V.S, Tegk.M, Validated HPLC method for Determining Related Substances in
Compatibility studies and Novel extended release formulation
for Ranolazine, J. Chromatography Separation Techniques, 2014, 5(1), 1-7
11.
G.L,
K.H, Agarwal N, Development and validation of stability indicating
RP-HPLC method for estimation of Ranolazine in bulk and tablet dosage
form. , International Research Journal of Pharmaceutical and Applied Sciences,
2012, 2(5), 217-223
12. Soujanya A, K.V.S, Puttagunta S, Method Development and
Validation for estimation of Ranolazine in its bulk and tablet dosage
form., International Journal of inventions in Pharmaceutical Sciences, 2013,
1(4), 363-369
13. Ganji R, D. R, G. S, Jayapal G, P.
R, Srilakshmi V, Development and Validation of stability indicating
RP-LC method for estimation of Ranolazine in bulk and its
Pharmaceutical formulation., American Journal of analytical Chemistry, 2012, 3,
378-384
14. A.M, Venkata S.D, P.S, A.N, Development and Validation of a
new analytical method for the Determination of related components and assay
of Ranolazine in bulk drug and pharmaceutical dosage forms by LC.,
J. Chromatographia, 2009, 70(1), 333-338
15. Sharma T, Moitra S.K, Si.S.C, Sankar D.G,
Stability indicating LC method for the determination
of Ranolazine Hydrochloride in the bulk drug and in pharmaceutical
dosage form. International Journal of Pharmacy and Pharmaceutical Sciences, 2011,
3(4), 327-332
16. Liang Y, Xie L, Liu XD, Chen WD, Lu
T, Xiong Y, Wang Gj, Simple, sensitive and rapid liquid
chromatography/atmospheric pressure chemical ionization mass spectrometric
method for the quantitation of Ranolazine in rat plasma.,
Rapid Commun Mass Spectrum, 2006, 20(4), 523-528
17. Lei T, Juanjuan J, Yiling H, Lu H, Hong
L, Yishi L, Sensitive quantification of Ranolazine in human
plasma by liquid chromatography-tandem mass spectrometry with
positive electrospray ionization., Journal of Chromatography B, 2007,
846(1-2), 346-350
18. Bai S, Gao H, Qu H, Liang Y, Li
Y, Zheng Z, Wang X, Hao G, Quantitative determination
of Ranolazine in human plasma by high performance liquid
chromatography-tandem mass spectrometry.Northwest Pharmaceutical Journal, 2011
19. Zhao L, Li H, Jiang Y, Piao R, Li P, Gu J
,Determination of Ranolazine in human plasma by liquid
chromatographic-tandem Mass Spectrometric assay, journal of Chromatographic
Science, 2008, 46(8), 697-700
20. Khedkar A.N, Veer S.U, Rakh M.S, Rao J.R,
Stability indicating method development and validation of
Ranolazine Hydrochloride in bulk and tablet dosage form by
HPTLC International Journal of
Pharmaceutical and Clinical Research, 2015, 7(1), 77-83
21. Chakraborty R, Pal K, Shaiba M, Sangepu N, P.S,
High performance thin layer
chromatographic,,estimation,of Ranolazine. Researh journal of
Pharmaceutical, Biological and Chemical Sciences, 2010, 1(4), 152-157
22. Boovizhikannan T, Palanirajan V, Estimation
of Ranolazine using Reverse phase High Performance liquid Chromatography
Technique., American journal of Pharma Tech Research, 2012, 2(6),
23. Herron W.J, Eadie J, Penman A.D, Estimation
of Ranolazine and eleven phase I metabolites in human plasma by
liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
with selected-ion monitoring .,Journal of Chromatography A, 1995, 712(1), 50-60
24. Rodrigo,A.S, Thiago B, Pierina S.B,Enantioselective analysisof Ranolazine and Desmethyl ranolazine in microsomal medium
using dispersive liquid-liquid microextraction and LC-MS/MS.
, J.Bioanalysis, 5(2), 171-183
25. Tan Q, Zhu R, Li H, Fang P, Yan M, Zhang Q, Peng W,
Development and Validation of a,sensitive,U-HPLC-MS/MS, method,
with electrospray ionization
for quantitation of Ranolazine in human plasma:
Application to a clinical pharmacokinetic study. , Journal of Chromatography B,
2012, 901, 119-124
26. Wang Y, Chen X, Sun Z, Yang Y, Liu W, Zhong D,
Development and Validation of a sensitive LC-MS/MS assay for
simultaneous quantitataion of Ranolazine and its three
metabolites in human plasma., Journal of Chromatography
B analyt Technology Biomed Life Sciences, 2012, 10(6), 889-890
27. Bhaumik U, Ghosh A, Sarkar A,,BoseA, Selvan P, Sengupta P, Chakraborty U, Ghosh D,
Pal T, Determination of Ranolazine in human plasma by LC-MS/MS and
its application in bioequivalence study., Journal of Pharmaceutical and
Biomedical Analysis, 2008, 48(5), 1404-1410
28. Luo X, Zhai Z, Wu X, Shi Y, Chen L, Li Y, Analytical
and semi-preparative resolution
of Ranolazine enantiomers by,liquid,chromatography using
polysaccharide chiral stationary phases., Journal of separation
science, 2006, 29(1), 164-171
29. Laha T, Padhy D, Sen S, A Validated
stability indicating reversed phase high performance liquid chromatography
method of Ranolazine Dihydrochloride and characterization of its
degradation products., International journal of Pharmacy and Pharmaceutical
sciences, 2013, 5(1), 61-66
30. Tang JY, Wang w, Li L, Zhang CG, Wang DM, Sun L, Analysis of
primary metabolites of Ranolazine in dog urine by LC-MS(n).,
Yao Xue Xue Bao, 2012, 47(8), 1031-1038
31. Zhong J, Liu X.Q, Chen Y, Zhao X.P, Wang Y.S, Wang G.J,
Determination of Ranolazine in rat plasma by liquid
chromatography-electrospray ionization mass spectrometry.,
J. Chromatographia, 2006, 63(3-4), 123-127
32. Malati V, Reddy
A.R, Mukkanti K, Suryanarayana M.V, A novel reversed phase
stability indicating RP-UPLC method for the quantitative determination of
fifteen related substances in Ranolazine drug substance and drug
product., J. Talanta, 2012, 97, 563-373.
33. Ye YL, Yang XM, Determination of residual solvent
in Ranolazine by headspace gas chromatography. , Nan Fang
Yi Ke Da Xue Bao, 2008, 28(1), 134-135
34. J.K, K.R, R.K, N.S, Method development and Validation for the Estimation
of Ranolazine in Bulk and in Pharmaceutical Dosage Form by
UV-Spectrophotometry., Annals of Pharma Research.
35. Ugale J. B, Mulgund S. V, Development and Validation of
UV Spectrophotometric Area under cure method for Quantitative Estimation
of Ranolazine in API and Tablet Formulation., World journal of Pharmaceutical
Research, 2015,4(5), 2665-2672
36. Guada M, Imbuluzqueta E, Estella-Hermoso de
Mendoza A, Lana H, Dios-vieitez M.C, Blanco-Prieto M.J, Ultra high
performance liquid chromatography-tandem mass spectrometry method for
cyclosporine a quantification in biological samples and
lipid nanosystems.,
J Chromatogr B Analyt Technol Biome Life Sci., 2013,
927, 164-172
37. Killedar S, Pawar A, Nadaf S, Nale A, Tamboli U, Pishawikar S,
Novel analytical method development for some amide group containing drugs using
Bougainvillea spectabilis bract extracts., Asian Pac
J Trop Med, 2014
38. S. R, L. K.S, M. N, N. K, V. S, M. A, Colorimetric Determination
of Ranolazine in Bulk and Synthetic Mixture., An Indian
Journal of Analytical Chemistry, 8(4), 572-574
39. Sambasivarao V and P, R.S.ch, Development of Rapid
Visible Spectrophotometric Methods for the Estimation
of Ranolazine in Formulation., International Journal
of Researh in Pharmacy and Chemistry, 2011, 1(1), 66-72
40. Bidada J. P, Gonjari I. D, Raut C.
S, Bhutada C. J, Novel Spectrophotometric method for estimation
of Ranolazine in bulk and pharmaceutical dosage forms., Scholars
Research Library, 2011, 3(2), 1-4
41. Singh R, Singh P, Malik P, Singh T,
Nandrop, Spectrophotometric method Development and Validation for estimation
of Ranolazine in their bulk., Journal of Chromatography A,1995,
712(1), 55-60.
42. Gowda DV, Gowrav MP, Gangadharappa HV,
Khan MS, Preparation and Evaluation of mixture
of Eudragit and Ethylcellulose Microparticles loaded
with Ranolazine for Controlled Release., Journal of Young
Pharmacists, 2011, 3(3), 189-196
43. Nahid A, Pavani H, Development and Validation of
HPLC method for
simultaneous determination of Ranolazine and Dronederone in
bulk and pharmaceutical dosage forms., Indian Journal of research in Pharmacy
and Biotechnology, 2015, 2(6), 1524-1528
44. Avvaru R, Prabakaran V, Analytical method development and
validation of RP-HPLC method for simultaneous estimation
of ranolazine and Dronederone in bulk., International
Journal of Pharma Sciences, 2015, 5(3), 1030-1035